10th November 2014
Polar Capital Global Healthcare Growth and Income Trust plc (the "Company")
Top Ten Equity Holdings - 31/10/2014
Polar Capital Global Healthcare Growth and Income Trust plc is pleased to announce that as at 31st October 2014 the top ten equity holdings and the sector breakdown were as follows:
Top 10 Holdings |
% |
Roche |
7.8% |
Merck & Co |
7.8% |
Eli Lilly & Co |
6.6% |
AstraZeneca |
6.0% |
Novartis |
5.1% |
Pfizer |
4.6% |
Abbvie |
4.2% |
Astellas Pharma |
3.9% |
Sanofi |
3.6% |
GlaxoSmithKline |
3.2% |
Total |
52.6% |
Sector Exposure |
% |
Pharmaceuticals |
66.6% |
Healthcare Equipment |
8.4% |
Healthcare Facilities |
5.3% |
Biotechnology |
4.7% |
Healthcare REITs |
3.8% |
Healthcare Services |
3.3% |
Healthcare Supplies |
0.9% |
Healthcare Distributors |
0.9% |
Life Sciences Tools & Services |
0.7% |
Life & Health Insurance |
0.4% |
Healthcare Technology |
0.4% |
Multi-line Insurance |
0.0% |
Cash |
4.6% |
Total |
100.0 |
A copy of the entire portfolio as at 30th September 2014 will be available to view shortly on the Company's website.
The monthly factsheet will usually be available on the Company's website on the 10th working day after the month end and includes a commentary by the investment manager. www.Polarcapitalhealthcaretrust.com
Neither the contents of the Company's website nor the contents of any website accessible from the hyperlinks on the Company's website (or any other website) is incorporated into or forms part of this announcement.